A Randomized, Placebo and Active-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence

Trial Profile

A Randomized, Placebo and Active-Controlled, Multi-Center Study of Probuphine in Patients With Opioid Dependence

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone
  • Indications Opioid abuse
  • Focus Registrational; Therapeutic Use
  • Sponsors Titan Pharmaceuticals
  • Most Recent Events

    • 05 Mar 2014 New trial record
    • 03 Mar 2014 Results have been published in the journal Addiction, according to a Titan Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top